In colon cancer, several studies have reported on the identification of cancer stem cells (CSC) earmarked by specific membrane-bound antigens such as CD133, CD44, and CD166, used to enrich for cells with tumor-propagating capacity in limiting dilution transplantation assays.3 The gene discussed is CD44; the disease is cancer.